Speakers

Sort by
Newest
Trending
1-6 of 6
Filter
Anna Schwabe
Cannabis Geneticist and Research Coordinator at Mile High Labs
alternative medicine, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis (drug), crohn's disease, drink, endocannabinoid system, entourage effect, gpr55, hash oil, immune system, immunodeficiency, liquor, moonshine, neuron, pharmaceutical industry, pharmacology, prohibition, receptor (biochemistry), tetrahydrocannabinol, weight training
Sean Colvin
Senior Scientist at TreeHouse Biotech
alternative medicine, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis (drug), crohn's disease, drink, endocannabinoid system, entourage effect, gpr55, hash oil, immune system, immunodeficiency, liquor, moonshine, neuron, pharmaceutical industry, pharmacology, prohibition, receptor (biochemistry), tetrahydrocannabinol, weight training
Tyrell Towle
Director of Chemistry at MedPharm Holdings
alternative medicine, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis (drug), crohn's disease, drink, endocannabinoid system, entourage effect, gpr55, hash oil, immune system, immunodeficiency, liquor, moonshine, neuron, pharmaceutical industry, pharmacology, prohibition, receptor (biochemistry), tetrahydrocannabinol, weight training
Julie P. Fry
Cannabis Industry Consultant
alternative medicine, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis (drug), crohn's disease, drink, endocannabinoid system, entourage effect, gpr55, hash oil, immune system, immunodeficiency, liquor, moonshine, neuron, pharmaceutical industry, pharmacology, prohibition, receptor (biochemistry), tetrahydrocannabinol, weight training
Joshua Jones
Founder at Jonesing Labs
alternative medicine, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis (drug), crohn's disease, drink, endocannabinoid system, entourage effect, gpr55, hash oil, immune system, immunodeficiency, liquor, moonshine, neuron, pharmaceutical industry, pharmacology, prohibition, receptor (biochemistry), tetrahydrocannabinol, weight training
Carter Baird
R&D Laboratory Technician at United Cannabis Corporation
absorption (pharmacology), alternative medicine, bioavailability, blood sugar level, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), chemist, concussion, crohn's disease, cytochrome p450, dose (biochemistry), drink, emotion, endocannabinoid system, entourage effect, enzyme, gpr55, hash oil, immune system, immunodeficiency, liposome, liquor, memory, micelle, milk, moonshine, nanotechnology, neuroimaging, neuron, pharmaceutical industry, pharmacokinetics, pharmacology, prohibition, receptor (biochemistry), receptor antagonist, surfactant, tetrahydrocannabinol, weight training
1